EnBio Holdings, Inc. (6092) Stock Statistics & Valuation Metrics

EnBio Holdings, Inc. has a market cap or net worth of ¥5.49B. The enterprise value is ¥12.27B.

EnBio Holdings, Inc. has 8,175,200 shares outstanding. The number of shares has decreased by -2.65% in one year.

EnBio Holdings, Inc.’s return on equity (ROE) is 0.05 and return on invested capital (ROIC) is 2.56%.

The current PE Ratio of EnBio Holdings, Inc. is 49.5. EnBio Holdings, Inc.’s PEG ratio is ―.

In the last 12 months, EnBio Holdings, Inc. had revenue of 10.67B and earned 452.69M in profits. Earnings per share was 55.90.

In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.

EnBio Holdings, Inc. pays an annual dividend of ¥9, resulting in a dividend yield of 1.34%

EnBio Holdings, Inc. upcoming earnings date is Nov 12, 2025, TBA (Confirmed).

EnBio Holdings, Inc. as a current ratio of 1.86, with Debt / Equity ratio of 110.48%

In the past 12 months, EnBio Holdings, Inc. has paid 281.90M in taxes.

EnBio Holdings, Inc. EV to EBITDA ratio is 8.69, with an EV/FCF ratio of -8.09.

EnBio Holdings, Inc. has ¥3.29B in cash and marketable securities with ¥10.10B in debt, giving a net cash position of ¥6.81B billion.

Gross margin is 24.87%, with operating margin of 7.95%, and net profit margin of 4.24%.

The average price target for EnBio Holdings, Inc. is ¥747.00, which is 11.43% higher than the current price. The consensus rating is Hold